Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 1;31(11):1028-1029.
doi: 10.1097/GME.0000000000002430. Epub 2024 Aug 21.

In reply

Pluvio J Coronado, Nicolás Mendoza, María Fasero

In reply

Pluvio J Coronado et al. Menopause. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Financial disclosure/conflicts of interest: P.J.C.: MSD, Shionogi, Adventia, Procare, Abex. M.F.: MSD, Organon, Theramex, Shionoghi. N.M.: Astellas Pharma, Shionogi.

References

    1. Coronado PJ, Gómez A, Iglesias E, et al. HMT Eligibility Criteria Group. Eligibility criteria for using menopausal hormone therapy in breast cancer survivors: a safety report based on a systematic review and meta-analysis. Menopause 2024;31:234–242. doi: 10.1097/GME.0000000000002317 - DOI
    1. Fahlén M, Fornander T, Johansson H, et al. Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial. Eur J Cancer 2013;49:52–59. doi: 10.1016/j.ejca.2012.07.003 - DOI
    1. Holmberg L, Iversen OE, Rudenstam CM, et al. HABITS Study Group. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors [published correction appears in J Natl Cancer Inst 2008;100(9):685. Maenpa, Johanna [corrected to Maenpaa, Johanna]]. J Natl Cancer Inst 2008;100:475–482. doi: 10.1093/jnci/djn058 - DOI
    1. Anderson GL, Chlebowski RT, Aragaki AK, et al. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial. Lancet Oncol 2012;13:476–486. doi: 10.1016/S1470-2045(12)70075-X - DOI
    1. Fasero M, Rejas-Gutiérrez J, Coronado PJ. Sensitivity-to-change and predictive validity of the Cervantes Short-Form (C-SF) questionnaire in postmenopausal women. Arch Gynecol Obstet 2023;307:481–491. doi: 10.1007/s00404-022-06787-8 - DOI

LinkOut - more resources